Publications by authors named "Sharon Marsh"

Claim this Profile
V
Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.
Olusola O Faluyi, Lawson Eng, Xin Qiu, Jiahua Che, Qihuang Zhang, Sharon Marsh

Cancer Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background.
Jinsheng Yu, Sharon Marsh, Junbo Hu, Wenke Feng, Chaodong Wu

Gastroenterol Res Pract· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Microbiota and Metagenomic Advancement in Digestive Disease.
Jinsheng Yu, Sharon Marsh, Junbo Hu, Wenke Feng, Chaodong Wu

Gastroenterol Res Pract· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients.
Sinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, Xin Qiu, Yonathan Brhane, Sharon Marsh

Cancer Epidemiol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic assessment of Mexican and Peruvian populations.
Sharon Marsh, Cristi R King, Derek J Van Booven, Jane Y Revollo, Robert H Gilman

Pharmacogenomics· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eHealth: past and future perspectives.
Tibor van Rooij, Sharon Marsh

Per Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bridging Opportunities Work-frame to develop mobile applications for clinical decision making.
Tibor van Rooij, Serena Rix, James B Moore, Sharon Marsh

Future Sci OA· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
Lawson Eng, Abul Kalam Azad, Xin Qiu, Qin Quinn Kong, Dangxiao Cheng, Sharon Marsh

Carcinogenesis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists.
Tibor van Rooij, Serena Rix, Sharon Marsh

Can Pharm J (Ott)· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and frugal trees: translating population-based pharmacogenomics to medication prioritization.
Tibor van Rooij, Mary Roederer, Todd Wareham, Iris van Rooij, Howard L McLeod, Sharon Marsh

Per Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrosequencing of clinically relevant polymorphisms.
Cristi R King, Sharon Marsh

Methods Mol Biol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics of third-generation aromatase inhibitors.
Abdullah Turkistani, Sharon Marsh

Expert Opin Pharmacother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized medicine policy challenges: measuring clinical utility at point of care.
Tibor van Rooij, Donna M Wilson, Sharon Marsh

Expert Rev Pharmacoecon Outcomes Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel markers for 5-FU and FOLFOX toxicity.
Sharon Marsh

Pharmacogenomics· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD133 as a marker of response to bevacizumab.
Sharon Marsh

Pharmacogenomics· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR R521K predicts cetuximab response in KRAS wild-type patients.
Sharon Marsh

Pharmacogenomics· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review.
Ivan Diaz-Padilla, Eitan Amir, Sharon Marsh, Geoffrey Liu, Helen Mackay

Gynecol Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PharmGKB summary: methotrexate pathway.
Torben S Mikkelsen, Caroline F Thorn, Jun J Yang, Cornelia M Ulrich, Deborah French, Sharon Marsh

Pharmacogenet Genomics· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin pathways: pharmacodynamics and adverse effects.
Caroline F Thorn, Connie Oshiro, Sharon Marsh, Tina Hernandez-Boussard, Howard McLeod

Pharmacogenet Genomics· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer.
Jill M Kolesar, Suzanne E Dahlberg, Sharon Marsh, Howard L McLeod, David H Johnson

Oncol Rep· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving oncology outcomes through targeted therapeutics will require electronic delivery systems.
Tibor van Rooij, Sharon Marsh

Future Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PharmGKB summary: fluoropyrimidine pathways.
Caroline F Thorn, Sharon Marsh, Michelle Whirl Carrillo, Howard L McLeod, Teri E Klein

Pharmacogenet Genomics· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Damming the genomic data flood using a comprehensive analysis and storage data structure.
Marc Bouffard, Michael S Phillips, Andrew M K Brown, Sharon Marsh, Jean-Claude Tardif

Database (Oxford)· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan pharmacogenomics.
Sharon Marsh, Janelle M Hoskins

Pharmacogenomics· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxane pathway.
Connie Oshiro, Sharon Marsh, Howard McLeod, Michelle Whirl Carrillo, Teri Klein

Pharmacogenet Genomics· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis